Schering NV, a prominent player in the pharmaceutical industry, is headquartered in Belgium (BE) and operates extensively across Europe and North America. Founded in the late 19th century, the company has a rich history marked by significant milestones in drug development and innovation. Specialising in prescription medicines, Schering NV focuses on areas such as oncology, immunology, and gynaecology, offering unique products that address unmet medical needs. Their commitment to research and development has positioned them as a leader in the biopharmaceutical sector, with notable achievements in advancing therapies that improve patient outcomes. With a strong market presence, Schering NV continues to drive progress in healthcare, leveraging cutting-edge technology and scientific expertise to deliver high-quality solutions that enhance the quality of life for patients worldwide.
How does Schering NV's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Schering NV's score of 93 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
As of the latest reporting, Schering NV does not have specific carbon emissions data available. However, the company is a current subsidiary of Bayer Aktiengesellschaft, which provides emissions data and climate commitments at a higher corporate level. Bayer Aktiengesellschaft has set ambitious climate targets, which Schering NV adheres to through its corporate family relationship. These targets include commitments to reduce greenhouse gas emissions across various scopes, including Scope 1, 2, and 3 emissions. The initiatives and targets cascaded from Bayer include participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which aim to drive significant reductions in carbon emissions. While Schering NV has not specified its own reduction targets, it aligns with Bayer's overarching climate strategies, which focus on sustainability and reducing the environmental impact of its operations. The company is committed to contributing to a more sustainable future, reflecting the industry's growing emphasis on climate responsibility. In summary, while specific emissions data for Schering NV is not available, the company is integrated into Bayer's comprehensive climate initiatives, which aim for substantial reductions in carbon emissions and adherence to global sustainability standards.
Access structured emissions data, company-specific emission factors, and source documents
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 
| Scope 2 | - | - | 0,000,000,000 | 0,000,000,000 | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 
| Scope 3 | 1,215 | 0,000 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 
Schering NV's Scope 3 emissions, which decreased by 16% last year and increased significantly since 2004, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 72% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 76% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Schering NV has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.